The progress of diagnostic and prognostic molecular markers of lymphoma.
10.3760/cma.j.issn.0253-2727.2015.04.022
- Author:
Ming ZHANG
1
,
2
;
Yuankai SHI
1
;
Xiaohong HAN
1
;
Author Information
1. Department of Medical Oncology, Cancer Institute/Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences
2. Beijing Key Laboratory of Clinical Study on Anticancer Molecular Target Drugs, Beijing 100021, China.
- Publication Type:Journal Article
- MeSH:
Biomarkers, Tumor;
Humans;
Lymphoma;
Prognosis
- From:
Chinese Journal of Hematology
2015;36(4):354-357
- CountryChina
- Language:Chinese
